Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%

August 17, 2023

Gossamer and Chiesi Join Forces for the Development of Their Pulmonary Arterial Hypertension (PAH) Drug

May 8, 2024

Ionis sees success in lipid reduction Phase 3 trial

September 26, 2023

Must Read

Eli Lilly’s Eloralintide Linked to Up to 20.1% Weight Loss in Phase 2 Study, Phase 3 Planned

November 7, 2025

Ivonescimab Shows 26% Reduction in Death Risk for EGFR-Mutated NSCLC Patients in Phase 3 Trial

November 7, 2025

Harmony Pauses Development of Cannabidiol Gel After Fragile X Trial Failure

November 7, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Eli Lilly’s Eloralintide Linked to Up to 20.1% Weight Loss in Phase 2 Study, Phase 3 Planned

Ivonescimab Shows 26% Reduction in Death Risk for EGFR-Mutated NSCLC Patients in Phase 3 Trial

Harmony Pauses Development of Cannabidiol Gel After Fragile X Trial Failure

Negative Confirmatory Study Results for Sarepta’s DMD Exon-Skippers

Zag Bio Launches with $80 Million Funding to Develop Thymus-Targeted Autoimmune Therapies

Hemab Secures $157 Million Series C to Advance Treatments for Rare Bleeding Disorders

Takeda Puts Up Over $11B For Innovent Cancer Assets

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Elon Musk Announces Neuralink’s Second Brain-Computer Chip Implantation in a Patient

Hovione and Zerion collaborate to market the technology program Dispersome®

Editor Picks

Two-Year Study Shows Nevro’s High-Frequency Neurostimulation Reduces Diabetic Neuropathy Pain by 80%

Gossamer and Chiesi Join Forces for the Development of Their Pulmonary Arterial Hypertension (PAH) Drug

Ionis sees success in lipid reduction Phase 3 trial

Must Read

Eli Lilly’s Eloralintide Linked to Up to 20.1% Weight Loss in Phase 2 Study, Phase 3 Planned

Ivonescimab Shows 26% Reduction in Death Risk for EGFR-Mutated NSCLC Patients in Phase 3 Trial

Harmony Pauses Development of Cannabidiol Gel After Fragile X Trial Failure

Hot Topics

About Us

Follow Us